Day: February 11, 2022

SYDNEY, AUSTRALIA, Feb. 11, 2022 (GLOBE NEWSWIRE) —  Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune disease, is pleased to announce the grant of a new patent (number 2016205983) entitled “Combined Preparations for the Treatment of Cancer or Infection” by the Australian Patent Office. This new Australian patent follows the grant of the corresponding European, United States and Chinese patents announced in 2018 through 2021. The claims of the new patent protect Immutep’s intellectual property relating to combined therapeutic preparations comprising (a) its lead active immunotherapy candidate eftilagimod alpha (“efti” or “IMP321”), which is a LAG-3 fusion protein (LAG-3Ig), and (b) an anti-PD-1 or...

The newly proposed workflow has 93% success rate compared to 9.6% success rate of traditional methods by eliminating cell culture, replacing karyotyping analysis with OGM for comprehensive SV analysis of fetal tissue and adding chromosomal microarray analysis of formalin-fixed, paraffin-embedded POC tissue to recover samples contaminated with maternal cells. SAN DIEGO, Feb. 11, 2022 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solution for visualization, interpretation and reporting of genomic data, today announced the first publication demonstrating OGM as an alternative to karyotyping (KT) for products of conception (POC) sample analysis. Chromosomal abnormalities are the most common cause of early pregnancy...

PHOENIX, Feb. 11, 2022 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corporation (Nasdaq: WSC) today announced that it will release its fourth quarter and full year 2021 financial results on Thursday, February 24, 2022, after the markets close. Chief Executive Officer, Brad Soultz and President and Chief Financial Officer, Tim Boswell will host a conference call and webcast on Friday, February 25, 2022, at 10:00 a.m. EST to discuss the results. The live call can be accessed by dialing (855) 312-9420 (US/Canada toll-free) or (210) 874-7774 (International). A live webcast will also be accessible via the “Events & Presentations” section of the company’s website www.willscotmobilemini.com. An archived version of the webcast will be available for 60 days following the call. About WillScot Mobile Mini Holdings WillScot Mobile...

EDISON, N.J., Feb. 11, 2022 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos”), a leading provider of safe, scalable, efficient, and sustainable zinc-based energy storage systems, today announced the date for the release of its fourth quarter and full-year 2021 financial results. Eos will release fourth quarter and full-year 2021 financial results before the U.S. market opens on February 25, 2022. A conference call to discuss its results will follow at 8:30 a.m. Eastern Time that same day. The conference call can be accessed live over the phone by dialing (877) 705-6003, or for international callers (201) 493-6725. The call will also be webcast live from Eos’s investor relations website at https://investors.eose.com. The conference call replay will be available via webcast through Eos’s investor...

Board of Directors Affirms its Commitment as Fiduciaries to Maximize Value Shareholders are not Required to Take any Action at this Time PHILADELPHIA, Feb. 11, 2022 (GLOBE NEWSWIRE) — The Board of Directors (the “Board”) of Republic First Bancorp, Inc. (the “Bank”) (NASDAQ: FRBK), the holding company for Republic Bank, today issued the following statement in response to recent Schedule 13D filings (the “Filings”) of a shareholder group (the “Shareholder Group”) with the Securities and Exchange Commission: “The Board is committed to discharging its fiduciary duty to the Bank, as well as its shareholders and the communities the Bank serves. Consistent with this duty, the Board continues to review the Filings by the Shareholder Group carefully and objectively in the same manner it would evaluate input from any shareholder or third...

REE co-founder & CEO Daniel Barel will talk about how REE’s technology, modular platforms, and business model can accelerate electrification for fleets during fireside chats, 1-on-1 and small group meetings TEL AVIV, Israel, Feb. 11, 2022 (GLOBE NEWSWIRE) — REE Automotive Ltd. (NASDAQ: “REE”), an automotive technology leader and provider of electric vehicle platforms, today announced that it will participate in a series of investor conferences in the first quarter of 2022. Daniel Barel, REE co-founder and chief executive officer and David Goldberg, REE chief financial officer, will discuss REE’s production progress on its newest fully-flat P7 platform for commercial fleets, go-to-market strategy with top partners for platforms and full vehicles, and strategy for developing a full ecosystem from charging infrastructure to Data-as-a-Service...

Patient mortality data continues to exceed expectations Recent FDA approved SOFA amendment contributing to increased patient enrollment TORONTO, Feb. 11, 2022 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (Dialco), today provided a clinical trial update on Tigris, a follow on study designed to build on knowledge gained from the earlier EUPHRATES trial, evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock. The Tigris trial end point is a reduction in the 28-day mortality...

LEXINGTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (NASDAQ: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that Keros’ President and Chief Executive Officer Jasbir S. Seehra, Ph.D. will present at the 11th Annual SVB Leerink Global Healthcare Conference on Friday, February 18th at 9:20 am ET. The fireside chat presentation will be webcast live at https://wsw.com/webcast/svbleerink67/register.aspx?conf=svbleerink67&page=kros&url=https://wsw.com/webcast/svbleerink67/kros/2687550 and archived in the Investors section of the Keros website at https://ir.kerostx.com/. A replay will be available...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, Feb. 11, 2022 (GLOBE NEWSWIRE) — Century Global Commodities Corporation (“Century” or the “Company”) (TSX: CNT) is pleased to announce that it has filed its condensed consolidated interim financial statements for the third fiscal quarter ended December 31, 2021 and the related management discussion and analysis (“MD&A”). Copies of these documents are available under Century’s SEDAR profile at www.sedar.com and will also be posted on Century’s website at www.centuryglobal.ca. As of December 31, 2021, the Company had strong working capital of $12.4 million, consisting of cash, bank deposits and marketable securities totaling $11.2 million, together with accounts receivable and other current assets of $3.7 million, less accounts...

Results for the Fourth Quarter 2021Net income of $9.9 million, or $0.42 per common unit Adjusted EBITDA of $12.2 million and distributable cash flow of $11.0 million Quarterly cash distribution declared of $0.44 per unit Distribution coverage ratio of 1.05xResults for the Full Year 2021Net income of $40.4 million, or $1.71 per common unit Adjusted EBITDA of $52.1 million and distributable cash flow of $45.4 million Distribution coverage ratio of 1.72xOMAHA, Neb., Feb. 11, 2022 (GLOBE NEWSWIRE) — Green Plains Partners LP (NASDAQ:GPP) today announced financial and operating results for the fourth quarter and full year of 2021. Net income attributable to the partnership was $9.9 million, or $0.42 per common unit, for the fourth quarter of 2021, compared with net income of $10.3 million, or $0.44 per common unit, for the same...